Get started
Author

Duncan T. Njenda

Observed names: Duncan Njenda, Duncan T Njenda, Njenda, Duncan
ORCID: 0000-0001-8276-9726
Observed ORCID: 0000-0001-8276-9726
OpenAlex ID: A5069340320
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
2017 · Ujjwal Neogi, Kamalendra Singh, et al. · AIDS · 34
Pleckstrin Levels Are Increased in Patients with Chronic Periodontitis and Regulated via the MAP Kinase-p38α Signaling Pathway in Gingival Fibroblasts
2022 · M. Abdul Alim, Duncan Njenda, et al. · Frontiers in Immunology · 16
HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon
2019 · Sello Given Mikasi, Josiah Otwoma Gichana, et al. · AIDS Research and Human Retroviruses · 15
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness
2019 · Robert van Domselaar, Duncan T. Njenda, et al. · Journal of Virology · 15
PDF
Antiretroviral potency of 4′-ethnyl-2′-fluoro-2′-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes
2018 · Duncan T Njenda, Shambhu G Aralaguppe, et al. · Journal of Antimicrobial Chemotherapy · 14
Strain-specific effect on biphasic DNA binding by HIV-1 integrase
2018 · Kyle J. Hill, Leonard C. Rogers, et al. · AIDS · 10
Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaoundé, Cameroon
2017 · George Mondinde Ikomey, Marie Claire Okomo Assoumou, et al. · GERMS · 8
Oncogenic Human Papillomavirus Genotypes 16 and 18 Prevalence Among Women with Normal Cervical Cytology and Neoplasia in Cameroon: A Systematic Review
2017 · Gilbert Ndeh Doh, George Mondinde Ikomey, et al. · HEALTH SCIENCES AND DISEASE · 8
PDF
Image based subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
2025 · Marianna Tampere, Trang H. Le, et al. · Biomedicine & Pharmacotherapy · 2
A Systematic Host-Centric Approach to Identifying Repurposed Drugs for Viral Infections
2025 · Marianna Tampere, Elin Asp, et al. · 1
A host-centric morphological profiling approach to identify repurposed antiviral drugs
2026 · Elin Asp, Jonne Rietdijk, et al. · iScience
A host-centric morphological profiling approach to identify repurposed antiviral drugs
2026 · Asp, Elin, Rietdijk, Jonne, et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Exploring the morphology of the host cell to open new possibilities for drug repurposing in viral infections
2023 · Marianna Tampere, Adelinn Kalman, et al.
PDF
From bedside to bench and back : future options for antiretroviral drugs in non-B HIV-1 subtypes
2020 · Duncan Njenda · SUNScholar (Stellenbosch University)
PDF
Lab-on-foil based portable μPCR for POC nucleic acid testing of HIV-1
2020 · Anna Ohlander, Indranil Bose, et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Lab-on-foil based portable microPCR for point-of-care nucleic acid testing of HIV-1
2017 · Anna Ohlander, Indranil Bose, et al.
Investigating the fitness benefit of reverse transcriptase (RT) mutation A62V when co-occurring with M184V and K65R in HIV-1 subtype C
2016 · Duncan Njenda · SUNScholar (Stellenbosch University)
PDF
Works count: 19
Citation count: 124
H-index: 8
I10-index: 6
Year
Topic
Type